Tailor-made molecular imprints for biological event intervention

Molecular imprints, which are crosslinked architectures containing specific molecular recognition cavities for targeting compounds, have recently transitioned from in vitro diagnosis to in vivo treatment. In current application scenarios, it has become an important topic to create new biomolecular recognition pathways through molecular imprinting, thereby inhibiting the pathogenesis and regulating the development of diseases. This review starts with a pathological analysis, mainly focusing on the corresponding artificial enzymes, enzyme inhibitors and antibody mimics with enhanced functions that are created by molecular imprinting strategies. Recent advances are highlighted in the use of molecular imprints as tailor-made nanomedicines for the prevention of three major diseases: metabolic syndrome, cancer, and bacterial/viral infections.

A Review of Sensing Applications of Molecularly Imprinted Fluorescent Carbon Dots for Food and Biological Sample Analysis

Molecularly imprinted fluorescent carbon dots (MI-FCDs) find numerous applications in analytical chemistry due to their outstanding photoluminescent properties and having specific pockets for the recognition of target molecules. Despite significant advances, practical applications of MI-FCDs-based fluorescent sensors are still in their initial stages. Therefore, the topical developments in the synthesis, working, and application of MI-FCDs for sensing various target species (e.g., pharmaceuticals, biomolecules, pesticides, food additives, and miscellaneous species) in food and biological media have been highlighted. Moreover, a careful evaluation has been made to select the best methods based on their performance in terms of analytical parameters. To expand the horizons of this field, important challenges and future directions for developing MI-FCDs for practical use are also presented. This review will highlight important aspects of MI-FCDs-based fluorescent sensors for their applicability in food science, material science, environmental science, nanoscience, and biotechnology.

Molecularly imprinted polymers (MIPs): emerging biomaterials for cancer theragnostic applications

Cancer is a disease caused by abnormal cell growth that spreads through other parts of the body and threatens life by destroying healthy tissues. Therefore, numerous techniques have been employed not only to diagnose and monitor the progress of cancer in a precise manner but also to develop appropriate therapeutic agents with enhanced efficacy and safety profiles. In this regard, molecularly imprinted polymers (MIPs), synthetic receptors that recognize targeted molecules with high affinity and selectivity, have been intensively investigated as one of the most attractive biomaterials for theragnostic approaches. This review describes diverse synthesis strategies to provide the rationale behind these synthetic antibodies and provides a selective overview of the recent progress in the in vitro and in vivo targeting of cancer biomarkers for diagnosis and therapeutic applications. Taken together, the topics discussed in this review provide concise guidelines for the development of novel MIP-based systems to diagnose cancer more precisely and promote successful treatment. Molecularly imprinted polymers (MIPs), synthetic receptors that recognize targeted molecules with high affinity and selectivity, have been intensively investigated as one of the most attractive biomaterials for cancer theragnostic approaches. This review describes diverse synthesis strategies to provide the rationale behind these synthetic antibodies and provides a selective overview of the recent progress in the in vitro and in vivo targeting of cancer biomarkers for diagnosis and therapeutic applications. The topics discussed in this review aim to provide concise guidelines for the development of novel MIP-based systems to diagnose cancer more precisely and promote successful treatment.

Enzyme-free colorimetric sensor based on molecularly imprinted polymer and ninhydrin for methamphetamine detection

Digital image colorimetry was applied to introduce a rapid, portable, and non-enzymatic test for methamphetamine measurements in urine. Imprinted polymer was synthesized in a simple, low-cost process and utilized for selective extraction of analyte from the sample in combination with the well-known ninhydrin color test. Applying the digital camera on a mobile phone, RGB basic color data were obtained, and calibration curves were developed for different concentrations of methamphetamine. Optimization of the test condition was carried out by changing some effective parameters such as extraction time and pH. The results were compared with some similar structural compounds indicating great potential for use as a selective and semi-quantitative field test for this drug. An acceptable linear range (5-100 μM) and detection limit (1.44 μM) as well as good agreement with the reference method, makes this fast portable method, an easy and reliable test for the analysis of methamphetamine in biological samples.

Fighting Antibiotic-Resistant Bacteria : Promising Strategies Orchestrated by Molecularly Imprinted Polymers

Infections caused by antibiotic-resistant bacteria are difficult and sometimes impossible to treat, making them one of the major public health problems of our time. We highlight how one unique material , molecularly imprinted polymers (MIPs), can orchestrate several strategies to fight this major societal issue. MIPs are tailor-made biomimetic supramolecular receptors that recognize and bind target molecules with a high affinity and selectivity, comparable to those of antibodies. While research on MIPs for combatting cancer has been constantly flourishing, comprehensive work on their involvement in combatting resistant superbugs has been rather scarce. This review aims at filling this gap. We will describe what are the causes of bacterial resistance and at which level MIPs can deploy their weapons. MIPs' targets can be biofilm constituents, quorum sensing messengers, bacterial surface proteins and antibiotic-deactivating enzymes, among others. We will conclude on the current challenges and future developments in this field.